Elemene (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Elemene" in English language version.

refsWebsite

Global rank English rank

11nih.gov

4^th place

10doi.org

2^nd place

4pherobase.com

low place

3semanticscholar.org

11^th place

8^th place

1mskcc.org

low place

7,046^th place

doi.org

Xie Q, Li F, Fang L, Liu W, Gu C (2020). "The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment". BioMed Research International. 2020: 6892961. doi:10.1155/2020/6892961. PMC 7054771. PMID 32149121.
Wang J, Li H, Yao Y, Ren Y, Lin J, Hu J, et al. (July 2018). "β-Elemene Enhances GAP-43 Expression and Neurite Outgrowth by Inhibiting RhoA Kinase Activation in Rats with Spinal Cord Injury". Neuroscience. 383: 12–21. doi:10.1016/j.neuroscience.2018.04.045. PMID 29751054. S2CID 21735344.
Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y, Yao Y (August 2011). "β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin". Oncology Reports. 26 (2): 405–13. doi:10.3892/or.2011.1276. PMID 21519795.
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH (June 2008). "Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation". Cancer Letters. 264 (1): 127–34. doi:10.1016/j.canlet.2008.01.049. PMID 18442668.
Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, et al. (April 2005). "Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death". Cellular and Molecular Life Sciences. 62 (7–8): 881–93. doi:10.1007/s00018-005-5017-3. PMID 15868411. S2CID 34767648.
Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, et al. (April 2005). "Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase". Cellular and Molecular Life Sciences. 62 (7–8): 894–904. doi:10.1007/s00018-005-5027-1. PMID 15868412. S2CID 20587371.
Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, et al. (2018). "Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy". International Journal of Nanomedicine. 13: 6279–6296. doi:10.2147/IJN.S174527. PMC 6186893. PMID 30349250.
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A, Wang W (February 2006). "Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors". Contemporary Clinical Trials. 27 (1): 70–82. doi:10.1016/j.cct.2005.07.002. PMID 16243588.
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A, Wang W (February 2006). "Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors". Contemporary Clinical Trials. 27 (1): 70–82. doi:10.1016/j.cct.2005.07.002. PMID 16243588.
Adio, A. M. (2009), (-)-trans-B-Elemene and related compounds: occurrence, synthesis, and anticancer activity,Tetrahedron, volume 65, issue 27, 5145-5159 | https://doi.org/10.1016/j.tet.2009.04.062

mskcc.org

"About Herbs, Botanicals & Other Products: Beta-elemene". Memorial Sloan–Kettering Cancer Center. 9 August 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

Xie Q, Li F, Fang L, Liu W, Gu C (2020). "The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment". BioMed Research International. 2020: 6892961. doi:10.1155/2020/6892961. PMC 7054771. PMID 32149121.
Wang J, Li H, Yao Y, Ren Y, Lin J, Hu J, et al. (July 2018). "β-Elemene Enhances GAP-43 Expression and Neurite Outgrowth by Inhibiting RhoA Kinase Activation in Rats with Spinal Cord Injury". Neuroscience. 383: 12–21. doi:10.1016/j.neuroscience.2018.04.045. PMID 29751054. S2CID 21735344.
Zhu T, Xu Y, Dong B, Zhang J, Wei Z, Xu Y, Yao Y (August 2011). "β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin". Oncology Reports. 26 (2): 405–13. doi:10.3892/or.2011.1276. PMID 21519795.
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH (June 2008). "Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation". Cancer Letters. 264 (1): 127–34. doi:10.1016/j.canlet.2008.01.049. PMID 18442668.
Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, et al. (April 2005). "Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death". Cellular and Molecular Life Sciences. 62 (7–8): 881–93. doi:10.1007/s00018-005-5017-3. PMID 15868411. S2CID 34767648.
Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, et al. (April 2005). "Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase". Cellular and Molecular Life Sciences. 62 (7–8): 894–904. doi:10.1007/s00018-005-5027-1. PMID 15868412. S2CID 20587371.
Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, et al. (2018). "Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy". International Journal of Nanomedicine. 13: 6279–6296. doi:10.2147/IJN.S174527. PMC 6186893. PMID 30349250.
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A, Wang W (February 2006). "Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors". Contemporary Clinical Trials. 27 (1): 70–82. doi:10.1016/j.cct.2005.07.002. PMID 16243588.
Peng X, Zhao Y, Liang X, Wu L, Cui S, Guo A, Wang W (February 2006). "Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors". Contemporary Clinical Trials. 27 (1): 70–82. doi:10.1016/j.cct.2005.07.002. PMID 16243588.

ncbi.nlm.nih.gov

Xie Q, Li F, Fang L, Liu W, Gu C (2020). "The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment". BioMed Research International. 2020: 6892961. doi:10.1155/2020/6892961. PMC 7054771. PMID 32149121.
Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, et al. (2018). "Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy". International Journal of Nanomedicine. 13: 6279–6296. doi:10.2147/IJN.S174527. PMC 6186893. PMID 30349250.

pherobase.com

"Floral Compound: alpha-elemene". Pherobase.com.
"Floral Compound: delta-elemene". Pherobase.com.
"Floral Compound: gamma-elemene". Pherobase.com.
"Semiochemical: beta-elemene". Pherobase.com.

semanticscholar.org

api.semanticscholar.org

Wang J, Li H, Yao Y, Ren Y, Lin J, Hu J, et al. (July 2018). "β-Elemene Enhances GAP-43 Expression and Neurite Outgrowth by Inhibiting RhoA Kinase Activation in Rats with Spinal Cord Injury". Neuroscience. 383: 12–21. doi:10.1016/j.neuroscience.2018.04.045. PMID 29751054. S2CID 21735344.
Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, et al. (April 2005). "Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death". Cellular and Molecular Life Sciences. 62 (7–8): 881–93. doi:10.1007/s00018-005-5017-3. PMID 15868411. S2CID 34767648.
Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, et al. (April 2005). "Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase". Cellular and Molecular Life Sciences. 62 (7–8): 894–904. doi:10.1007/s00018-005-5027-1. PMID 15868412. S2CID 20587371.